This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Jennifer Aniston Announced As EIF Ambassador To Saks Fifth Avenue’s 2013 Key To The Cure Campaign

Stocks in this article: SKS

Saks Fifth Avenue and the Entertainment Industry Foundation (EIF) announced today that actress Jennifer Aniston has been named the EIF ambassador for Saks Fifth Avenue’s 2013 Key To The Cure campaign. In the 14 years since the inception of the Saks Fifth Avenue charity shopping weekend, the company, together with its vendors and partners, has raised over $33 million for cancer research.

Celebrated designer Peter Dundas of Emilio Pucci created a limited-edition T-shirt exclusively to benefit Key To The Cure that will retail for $35 at Saks Fifth Avenue stores, Saks Fifth Avenue OFF 5TH stores and online at saks.com. One hundred percent of the proceeds from each shirt sold will be donated to EIF’s Women’s Cancer Research Fund, benefiting charitable programs dedicated to finding new detection methods, better treatments and eventual cures for women’s cancers. The T-shirt debuts at Saks Fifth Avenue on October 1.

“I’m so honored to join the Entertainment Industry Foundation and Saks Fifth Avenue in their continued efforts to raise funds for promising scientific research through EIF’s Women’s Cancer Research Fund,” said Jennifer Aniston. “My hope is that everyone will contribute to this worthy cause by purchasing a Key To The Cure T-shirt designed by Emilio Pucci.“

Steve Sadove, Chairman and CEO, Saks Fifth Avenue, said, “We are so pleased to be partnering with Peter Dundas and Emilio Pucci, EIF’s Women’s Cancer Research Fund, and Jennifer Aniston this year for Key To The Cure. In our 15 th year, the continued support of our charity affiliates and efforts made by our clients, vendors and associates have proven to be a true testament to the Key To The Cure legacy.”

“I am proud for Emilio Pucci to be part of such an important initiative with Saks Fifth Avenue. I think every living person has been touched by this disease through the illness or even loss of a friend or a family member. I have. It would seem that in 2013 this would no longer be a worry, but it very much is and so the fight continues,” stated designer Peter Dundas.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,672.60 -141.38 -0.79%
S&P 500 2,051.82 -11.33 -0.55%
NASDAQ 4,757.8790 +7.4820 0.16%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs